Population-based assessment of disease-free survival (DFS) as a surrogate endpoint (SE) of 5-year overall survival (5Y OS) in stage I-III rectal (RC) and colon cancer (CC).

被引：0
|
作者：
Lee-Ying, Richard M.
Yin, Yaling
Lim, Howard John
Cheung, Winson Y.
Kennecke, Hagen F.
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] British Columbia Canc Agcy, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.3602
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3602
引用
收藏
页数：2
相关论文
共 29 条
  • [1] Correlation between 2 or 3 year (y) disease-free survival (DFS) and 5y overall survival (OS) in adjuvant systemic trials of early stage breast cancer.
    Ng, R. C. H.
    Pond, G. R.
    Tang, P. A.
    Siu, L. L.
    Chen, E. X.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S106 - S106
  • [2] Population-based assessment of surrogate endpoints (SE) in stage I-III colon (CCa) and rectal cancers (RCa).
    Lee-Ying, Richard M.
    Speers, Caroline
    Gresham, Gillian
    McConnell, Yarrow Jean
    Cheung, Winson Y.
    Kennecke, Hagen F.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Dynamic Prediction of 5-year Overall Survival in Stage I,II,III Colon Cancer Patients
    Battagello, J.
    Capelli, G.
    Restivo, A.
    Bao, Q.
    Deidda, S.
    Zorcolo, L.
    Pucciarelli, S.
    Zorzi, M.
    Spolverato, G.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S78 - S79
  • [4] Disease-free survival (DFS) as a surrogate endpoint (SE) for overall survival (OS) in early-stage resected esophageal/gastroesophageal junction cancer (EC/GEJC): An analysis of SEER-Medicare data.
    Ajani, Jaffer A.
    Leung, Lisa
    Kanters, Steve
    Singh, Prianka
    Kurt, Murat
    Kim, Inkyu
    Pourrahmat, Mir-Masoud
    Friedman, Howard S.
    Navaratnam, Prakash
    Reardon, Gregory
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 321 - 321
  • [5] Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials
    Petrelli, Fausto
    Borgonovo, Karen
    Cabiddu, Mary
    Ghilardi, Mara
    Lonati, Veronica
    Barni, Sandro
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (01) : 39 - 48
  • [6] Overall survival (OS) and updated disease-free survival (DFS) results of the NSABP C-08 trial assessing bevacizumab (B) in stage II and III colon cancer
    Allegra, C. J.
    Yothers, G. A.
    O'Connell, M. J.
    Sharif, S.
    Petrelli, N. J.
    Colangelo, L. H.
    Wolmark, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Correlation between changes in 2-or 3-year disease-free survival (DFS) and 5-year overall survival (OS) in adjuvant breast cancer trials from 1966-2006
    Ng, R. C.
    Pond, G. R.
    Tang, P. A.
    MacIntosh, P. W.
    Siu, L. L.
    Chen, E. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] RANDOMISED PHASE III TRIAL OF CAPECITABINE plus OXALIPLATIN VS. BOLUS 5-FU/LV FOR STAGE III COLON CANCER (NO16968): IMPACT OF AGE ON DISEASE-FREE SURVIVAL (DFS) OR OVERALL SURVIVAL (OS)
    Haller, D.
    Cassidy, J.
    Tabernero, J.
    Maroun, J. A.
    De Braud, F.
    Price, T. J.
    van Cutsem, E.
    Hill, M.
    Gilberg, F.
    Schmoll, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 207 - 207
  • [9] Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival
    Viehl, Carsten T.
    Weixler, Benjamin
    Guller, Ulrich
    Dell-Kuster, Salome
    Rosenthal, Rachel
    Ramser, Michaela
    Banz, Vanessa
    Langer, Igor
    Terracciano, Luigi
    Sauter, Guido
    Oertli, Daniel
    Zuber, Markus
    CANCER MEDICINE, 2017, 6 (05): : 918 - 927
  • [10] Does 5-year disease-free survival correlate with 5-year overall survival in adjuvant taxane-based chemotherapy for breast cancer? Analysis of randomized clinical trials
    Cuppone, Federica
    Bria, Emilio
    Ciccarese, Mariangela
    Nistico, Cecilia
    Carlini, Paolo
    Natoli, Guido
    Nuzzo, Carmen
    Terzoli, Edmondo
    Cognetti, Francesco
    Giannarelli, Diana
    ANNALS OF ONCOLOGY, 2006, 17 : 98 - 98
123